Evofem Biosciences (EVFM): FDA approved, can it maintain upwards momentum?
Evofem Biosciences (EVFM) has recently been given FDA approval Phexxi, a lactic acid, citric acid and potassium bitartrate vaginal gel for the prevention of pregnancy
Evofem Biosciences (EVFM) has recently been given FDA approval Phexxi, a lactic acid, citric acid and potassium bitartrate vaginal gel for the prevention of pregnancy
As you may notice there are tons of businesses that come and go, but here are 2 company stocks Visa (V) and Amazon (AMZN) that
AgEagle Aerial Systems (UAVS) rises on rumor of leaked news of Amazon (AMZN) or a major eCommerce company. Although there is no evidence found only
Aytu Bioscience (AYTU) has endured a hard weekend of events with people trying to censor the company because Trump said ‘ultra violet light.’ The horrible
ChromaDex Corporation [CDXC] is following upward pattern in the market concluded with the last trading session. The shares of the Health care sector business has
Baker Hughes Business [NYSE: BKR] acquired by 3.27% on the last trading session, reaching $13.41 cost per share at the time. Baker Hughes Business represents
Altus Midstream Business [ALTM] took an upward turn with a modification of 7.22%, trading at the rate of $0.57 throughout the trading session on Wednesday.
Southwest Airlines Co. [LUV] took a down turn with a modification of -0.27%, trading at the rate of$30.03 throughout the trading session on Tuesday. The
Today the vessel giant Seanergy Maritime (SHIP) that operates as an international shipping company specializing in the worldwide seaborne transportation of dry bulk commodities and
Liberty Trip Advisor (LTRPA, LTRPB) continues to make intraday big moves from $37 to $57 while halting continues. Liberty Trip Advisor (LTRPA, LTRPB) has released
Stockpence is currently seeking to expand our team of contributors. We’re looking for financial gurus & article writers to write about trending market news and investment ideas about the stock market.
If you’re interested please contact us!
Investing involves substantial risk. Neither the authors, the publisher, nor any of their respective affiliates make any guarantee or other promise as to any results that may be obtained from the articles herein. No reader should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, on any featured company here.
Some of the companies featured here may pay a fee to an affiliate of the publication to broaden awareness of said company.
The principals of the publication may buy or sell shares of the featured companies from time-to-time.
Join our free mailing list below to receive real-time news alerts and our next featured stock!
Investing involves substantial risk. Neither the Authors, the publisher, nor any of their respective affiliates make any guarantee or other promise as to any results that may be obtained from the articles herein. No reader should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, on any featured company here.
Some of the companies featured here may pay a fee to an affiliate of the publication to broaden awareness of said company.
The principals of the publication may buy or sell shares of the featured companies from time-to-time.
Join our free mailing list below to receive real-time news alerts and our next featured stock!